Table 2.

Sevoflurane usage during the study period

	Group K (n=15)	Group P (n=15)
End-expiratory sevoflurane concentration (%)	1.1 ± 0.04	1.1 ± 0.06
Sevoflurane consumption (mL)	12.4 ± 1.2	13.1 ± 1.8

Data are mean ± SD